Angiogene Inc.
Records under this name other than the patents Angiogene Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 7 of 7 · Back to Angiogene Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,629,131 | Rabbit monoclonal antibodies against mouse/human Id3 proteins Lapsed on the fee record Ended Dec 8, 2017 · From the USPTO record | Lapsed on the fee record | Ended Dec 8, 2017 | From the USPTO record |
| US 7,517,663 | Rabbit monoclonal antibody against Id1 protein Lapsed on the fee record Ended Apr 14, 2017 · From the USPTO record | Lapsed on the fee record | Ended Apr 14, 2017 | From the USPTO record |
| US 8,088,893 | Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions Lapsed on the fee record Ended Jan 3, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jan 3, 2016 | From the USPTO record |
| US 7,608,698 | Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions Lapsed on the fee record Ended Oct 27, 2013 · From the USPTO record | Lapsed on the fee record | Ended Oct 27, 2013 | From the USPTO record |
| US 6,626,928 | Occlusion device for treating aneurysm and use therefor Lapsed on the fee record Ended Sep 30, 2007 · From the USPTO record | Lapsed on the fee record | Ended Sep 30, 2007 | From the USPTO record |
| US 6,339,071 | Antisense oligonucleotide modulating cyclin E gene expression and therapeutic uses thereof Lapsed on the fee record Ended Jan 15, 2006 · From the USPTO record | Lapsed on the fee record | Ended Jan 15, 2006 | From the USPTO record |
| US 5,821,354 | Radiolabeled DNA oligonucleotide and method of preparation Formerly held Term ended Term ended no later than Oct 13, 2018 · Low confidence | Term ended | Term ended no later than Oct 13, 2018 | Low confidence |